Ashland Inc. Files 2024 10-K

TL;DR

Ashland's 2024 10-K is in. Full financials and biz ops detailed.

AI Summary

Ashland Inc. filed its 10-K for the fiscal year ending September 30, 2024, reporting its financial performance and business operations. The company, formerly known as Ashland Global Holdings Inc. until a name change on May 17, 2016, is headquartered in Wilmington, Delaware. The filing provides detailed financial statements and disclosures as required by the SEC.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Ashland's financial health and strategic direction for the past fiscal year, influencing investment decisions.

Risk Assessment

Risk Level: low — This is a standard annual financial filing with no immediate red flags or unusual disclosures.

Key Players & Entities

• Ashland Inc. (company) — Filer of the 10-K
• Ashland Global Holdings Inc. (company) — Former name of the filer
• 20240930 (date) — Fiscal year end date
• 20160517 (date) — Date of former company name change
• Wilmington, Delaware (location) — Company headquarters

FAQ

Key Financial Figures

• $221 m — ed environmental litigation amounted to $221 million, reflecting Ashland's estimates o
• $485 million — sites could be as high as approximately $485 million. The largest reserve for any site is 21
• $56 million — t of insurance receivables, amounted to $56 million in 2024 compared to $59 million in 2023
• $59 million — nted to $56 million in 2024 compared to $59 million in 2023 and $66 million in 2022. Prod
• $66 million — 024 compared to $59 million in 2023 and $66 million in 2022. Product Control, Registratio

Filing Documents

• ash-20240930.htm (10-K) — 7814KB
• ash-ex4_8c.htm (EX-4.8(C)) — 219KB
• ash-ex10_65.htm (EX-10.65) — 58KB
• ash-ex10_66.htm (EX-10.66) — 99KB
• ash-ex10_67.htm (EX-10.67) — 55KB
• ash-ex10_68.htm (EX-10.68) — 103KB
• ash-ex19_1.htm (EX-19.1) — 124KB
• ash-ex21.htm (EX-21) — 108KB
• ash-ex23_1.htm (EX-23.1) — 15KB
• ash-ex23_2.htm (EX-23.2) — 5KB
• ash-ex24.htm (EX-24) — 39KB
• ash-ex31_1.htm (EX-31.1) — 18KB
• ash-ex31_2.htm (EX-31.2) — 19KB
• ash-ex32.htm (EX-32) — 12KB
• ash-ex97.htm (EX-97) — 45KB
• img118337019_0.jpg (GRAPHIC) — 16KB
• img139792541_0.jpg (GRAPHIC) — 95KB
• img139792541_1.jpg (GRAPHIC) — 40KB
• img139792541_2.jpg (GRAPHIC) — 39KB
• img248105768_0.jpg (GRAPHIC) — 6KB
• img249029289_0.jpg (GRAPHIC) — 6KB
• img249952810_0.jpg (GRAPHIC) — 6KB
• img250876331_0.jpg (GRAPHIC) — 6KB
• 0000950170-24-128009.txt ( ) — 33369KB
• ash-20240930.xsd (EX-101.SCH) — 3220KB
• ash-20240930_htm.xml (XML) — 8052KB

Business

Business 4 General 4 Life Sciences 5 Personal Care 5 Specialty Additives 6 Intermediates 7 Miscellaneous 7 Item 1A.

Risk Factors

Risk Factors 14 Item 1B. Unresolved Staff Comments 22 Item 1C. Cybersecurity 22 Item 2.

Properties

Properties 23 Item 3.

Legal Proceedings

Legal Proceedings 23 Item 4. Mine Safety Disclosures 25 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 26 Item 6. [Reserved] 27 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operation

Management's Discussion and Analysis of Financial Condition and Results of Operation 27 Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 27 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 27 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 27 Item 9A.

Controls and Procedures

Controls and Procedures 27 Item 9B. Other Information 28 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 28 PART III Item 10. Directors, Executive Officers and Corporate Governance 29 Item 11.

Executive Compensation

Executive Compensation 29 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 29 Item 13. Certain Relationships and Related Transactions, and Director Independence 30 Item 14. Principal Accountant Fees and Services 30 PART IV Item 15. Exhibits and Financial Statement Schedules 31 Item 16. Form 10-K Summary 38 PART I

BUSINESS

ITEM 1. BUSINESS GENERAL Ashland Inc. is a Delaware corporation, with its headquarters and principal executive offices at 8145 Blazer Drive, Wilmington, Delaware 19808. Our common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol "ASH". The terms "Ashland" and the "Company" as used herein include Ashland Inc., its predecessors, and its consolidated subsidiaries, except where the context indicates otherwise. Ashland is a global specialty additives and materials company with a conscious and proactive mindset for sustainability. The Company serves customers in a wide range of consumer and industrial markets including, architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. With approximately 3,200 employees worldwide, Ashland serves customers in more than 100 countries. Ashland's reportable segments include: Life Sciences; Personal Care; Specialty Additives; and Intermediates. Unallocated and Other includes corporate governance activities and certain legacy matters. Life Sciences is comprised of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films (formerly known as advanced materials) and fine chemicals. Pharmaceutical solutions include controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers and tablet binders. Nutrition solutions include thickeners, stabilizers, emulsifiers and additives for enhancing mouthfeel, controlling moisture migration, reducing oil uptake and binding structured foods. Customers include pharmaceutical, food, beverage, hospitals and radiologists and industrial manufacturers. The nutraceuticals business was sold in August 2024. Personal Care is comprised of biofunctionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. These businesses have a broad range of natural, nature-derived, biodegradable, and high-performance ingredients for customer-driven solutions to

View Full Filing

View this 10-K filing on SEC EDGAR